Leonard Buckbinder
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- NF-κB Signaling Pathways
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 5
- Melanoma and MAPK Pathways 4
- Genetics 10
- Virus-based gene therapy research 5
- Co-authors
- Bernd R. Seizinger (5 shared papers)Nikolai Kley (5 shared papers)Randy Talbott (4 shared papers)Susana Velasco-Miguel (3 shared papers)Barbara Faha (1 shared paper)Ivone M. Takenaka (1 shared paper)Donald D. Brown (2 shared papers)Danny Reinberg (5 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of Medicinal Chemistry (3 papers)Drug Metabolism and Disposition (2 papers)ACS Chemical Biology (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Leonard Buckbinder
35 papers receiving 2.9k citations
Leonard Buckbinder's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 513
- Oncology 704
- Molecular Biology 1.7k
- Endocrinology, Diabetes and Metabolism 418
- Immunology 439
Countries citing papers authored by Leonard Buckbinder
This map shows the geographic impact of Leonard Buckbinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Buckbinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Buckbinder more than expected).
Fields of papers citing papers by Leonard Buckbinder
This network shows the impact of papers produced by Leonard Buckbinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Buckbinder. The network helps show where Leonard Buckbinder may publish in the future.
Co-authors
The 25 scholars most cited alongside Leonard Buckbinder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of the growth inhibitor IGF-binding protein 3 by p53 Hit paper breakdown → | 1995 | 741 |
| 2 | 2005 | 372 | |
| 3 | 1999 | 207 | |
| 4 | 1991 | 157 | |
| 5 | 1993 | 106 | |
| 6 | 1992 | 100 | |
| 7 | 2020 | 92 | |
| 8 | 2016 | 90 | |
| 9 | 2015 | 88 | |
| 10 | 1997 | 87 | |
| 11 | 2009 | 86 | |
| 12 | 1989 | 84 | |
| 13 | 1994 | 76 | |
| 14 | 2009 | 75 | |
| 15 | 1988 | 63 | |
| 16 | 1989 | 62 | |
| 17 | 2003 | 51 | |
| 18 | 2009 | 37 | |
| 19 | 2010 | 36 | |
| 20 | 2009 | 36 |
About Leonard Buckbinder
Leonard Buckbinder is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Immunology and Allergy, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Cell Adhesion Molecules Research (6 papers), Virus-based gene therapy research (5 papers), Cancer-related Molecular Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Nitric Oxide and Endothelin Effects (5 papers), Melanoma and MAPK Pathways (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (513 citations), Oncology (704 citations), Molecular Biology (1.7k citations), Endocrinology, Diabetes and Metabolism (418 citations) and Immunology (439 citations). Leonard Buckbinder has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Bernd R. Seizinger, Nikolai Kley, Randy Talbott, Susana Velasco-Miguel, Barbara Faha, Ivone M. Takenaka, Donald D. Brown, Danny Reinberg, Juan M. Cárcamo and Hiroyasu Nakano. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry, Drug Metabolism and Disposition and ACS Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.